{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:57:12Z","timestamp":1790045832998,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007234","name":"The University of Chicago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007234","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","ajog.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ajog.2024.02.023","type":"journal-article","created":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T06:22:12Z","timestamp":1708237332000},"page":"111.e1-111.e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Fertility protection: a novel approach using pretreatment with mesenchymal stem cell exosomes to prevent chemotherapy\u2013induced ovarian damage in a mouse model"],"prefix":"10.1016","volume":"231","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9130-8478","authenticated-orcid":false,"given":"Hang-soo","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Seok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mousaei","family":"Ghasroldasht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzana","family":"Liakath Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanaa","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Alkelani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Al-Hendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2024.02.023_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/GCO.0000000000000278","article-title":"Endocrine prevention of chemotherapy-induced ovarian failure","volume":"28","author":"Blumenfeld","year":"2016","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.02.023_bib2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2165\/00002018-200528050-00004","article-title":"Chemotherapy-induced ovarian failure: manifestations and management","volume":"28","author":"Molina","year":"2005","journal-title":"Drug Saf"},{"key":"10.1016\/j.ajog.2024.02.023_bib3","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.3390\/curroncol29110677","article-title":"Reproductive outcomes in young breast cancer survivors treated (15\u201339) in Ontario, Canada","volume":"29","author":"Rushton","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ajog.2024.02.023_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20215342","article-title":"The impact of chemotherapy on the ovaries: molecular aspects and the prevention of ovarian damage","volume":"20","author":"Sonigo","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajog.2024.02.023_bib5","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1200\/JCO.1996.14.5.1718","article-title":"Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer","volume":"14","author":"Bines","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ajog.2024.02.023_bib6","first-page":"105","article-title":"Immediate and long-term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at M.D. Anderson Hospital and Tumor Institute","author":"Hortobagyi","year":"1986","journal-title":"NCI Monogr"},{"key":"10.1016\/j.ajog.2024.02.023_bib7","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1200\/JCO.2005.03.3969","article-title":"Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study","volume":"24","author":"Petrek","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2024.02.023_bib8","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1200\/JCO.2006.08.8534","article-title":"Leuprorelin acetate every-3-months depot versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment in premenopausal patients with node-positive breast cancer: the TABLE study","volume":"25","author":"Schmid","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2024.02.023_bib9","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1200\/JCO.2006.07.2793","article-title":"Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer","volume":"24","author":"Walshe","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2024.02.023_bib10","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2217\/fon-2016-0176","article-title":"Chemotherapy-induced damage to ovary: mechanisms and clinical impact","volume":"12","author":"Bedoschi","year":"2016","journal-title":"Future Oncol"},{"key":"10.1016\/j.ajog.2024.02.023_bib11","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1080\/09513590.2017.1393661","article-title":"Bone marrow derived mesenchymal stem cells transplantation rescues premature ovarian insufficiency induced by chemotherapy","volume":"34","author":"Bao","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2024.02.023_bib12","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1007\/s43032-021-00528-z","article-title":"Human mesenchymal stem cell therapy and other novel treatment approaches for premature ovarian insufficiency","volume":"28","author":"Ulin","year":"2021","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2024.02.023_bib13","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1186\/s13287-020-01972-5","article-title":"Human umbilical cord mesenchymal stem cells restore the ovarian metabolome and rescue premature ovarian insufficiency in mice","volume":"11","author":"Zhao","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.ajog.2024.02.023_bib14","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00109-021-02055-5","article-title":"Premature ovarian insufficiency: pathogenesis and therapeutic potential of mesenchymal stem cell","volume":"99","author":"Takahashi","year":"2021","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.ajog.2024.02.023_bib15","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1007\/s43032-023-01300-1","article-title":"Potential therapeutic options for premature ovarian insufficiency: experimental and clinical evidence","volume":"30","author":"Ding","year":"2023","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2024.02.023_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/5760011","article-title":"A\u00a0Review on Treatment of Premature Ovarian Insufficiency: characteristics, Limitations, and Challenges of Stem Cell versus ExosomeTherapy","volume":"2023","author":"Elahi","year":"2023","journal-title":"Vet Med Int"},{"key":"10.1016\/j.ajog.2024.02.023_bib17","first-page":"2247","article-title":"Stem-cell-derived extracellular vesicles: unlocking new possibilities for treating diminished ovarian reserve and premature ovarian insufficiency","volume":"13","author":"Martirosyan","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1016\/j.ajog.2024.02.023_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1205901","article-title":"Human UC-MSC-derived exosomes facilitate ovarian renovation in rats with chemotherapy-induced premature ovarian insufficiency","volume":"14","author":"Pu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ajog.2024.02.023_bib19","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s12015-023-10576-4","article-title":"Efficacy of mesenchymal stem cell-derived extracellular vesicles in the animal model of female reproductive diseases: a meta-analysis","volume":"19","author":"Zhou","year":"2023","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.ajog.2024.02.023_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2023.103971","article-title":"Human umbilical cord mesenchymal stem cell-derived extracellular vesicles improve ovarian function in rats with primary ovarian insufficiency by carrying miR-145-5p","volume":"158","author":"Lu","year":"2023","journal-title":"J\u00a0Reprod Immunol"},{"key":"10.1016\/j.ajog.2024.02.023_bib21","first-page":"118","article-title":"Amniotic fluid-derived exosomes attenuated fibrotic changes in POI rats through modulation of the TGF-\u03b2\/Smads signaling pathway","volume":"16","author":"Nazdikbin Yamchi","year":"2023","journal-title":"J\u00a0Ovarian Res"},{"key":"10.1016\/j.ajog.2024.02.023_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13287-023-03397-2","article-title":"Comparison of the therapeutic effects between stem cells and exosomes in primary ovarian insufficiency: as promising as cells but different persistency and dosage","volume":"14","author":"Park","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.ajog.2024.02.023_bib23","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41374-019-0321-y","article-title":"Bone marrow mesenchymal stem cell-derived exosomal miR-144-5p improves rat ovarian function after chemotherapy-induced ovarian failure by targeting PTEN","volume":"100","author":"Yang","year":"2020","journal-title":"Lab Invest"},{"key":"10.1016\/j.ajog.2024.02.023_bib24","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1002\/cam4.4615","article-title":"miRNA-122-5p in POI ovarian-derived exosomes promotes granulosa cell apoptosis by regulating BCL9","volume":"11","author":"Zhang","year":"2022","journal-title":"Cancer Med"},{"key":"10.1016\/j.ajog.2024.02.023_bib25","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s13287-020-01866-6","article-title":"Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia","volume":"11","author":"Akbari","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.ajog.2024.02.023_bib26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12015-020-10109-3","article-title":"Proposed mechanisms of targeting COVID-19 by delivering mesenchymal stem cells and their exosomes to damaged organs","volume":"17","author":"Jamshidi","year":"2021","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.ajog.2024.02.023_bib27","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/leu.2014.41","article-title":"MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease","volume":"28","author":"Kordelas","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.ajog.2024.02.023_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40824-016-0068-0","article-title":"Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases","volume":"20","author":"Nassar","year":"2016","journal-title":"Biomater Res"},{"key":"10.1016\/j.ajog.2024.02.023_bib29","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1089\/scd.2020.0080","article-title":"Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19","volume":"29","author":"Sengupta","year":"2020","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.ajog.2024.02.023_bib30","article-title":"Therapeutic potential of pretreatment with exosomes derived from stem cells from the apical papilla against cisplatin-induced acute kidney injury","volume":"23","author":"Huang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajog.2024.02.023_bib31","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1038\/s41598-017-02786-x","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells protect against cisplatin-induced ovarian granulosa cell stress and apoptosis in\u00a0vitro","volume":"7","author":"Sun","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajog.2024.02.023_bib32","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1038\/s41598-021-84216-7","article-title":"Human BM-MSC secretome enhances human granulosa cell proliferation and steroidogenesis and restores ovarian function in primary ovarian insufficiency mouse model","volume":"11","author":"Park","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajog.2024.02.023_bib33","doi-asserted-by":"crossref","DOI":"10.1177\/0963689720988502","article-title":"Safety of intraovarian injection of human mesenchymal stem cells in a premature ovarian insufficiency mouse model","volume":"30","author":"Park","year":"2021","journal-title":"Cell Transplant"},{"key":"10.1016\/j.ajog.2024.02.023_bib34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1743-1050-3-2","article-title":"Comparative analysis of follicle morphology and oocyte diameter in four mammalian species (mouse, hamster, pig, and human)","volume":"3","author":"Griffin","year":"2006","journal-title":"J\u00a0Exp Clin Assist Reprod"},{"key":"10.1016\/j.ajog.2024.02.023_bib35","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1200\/JCO.2013.49.2678","article-title":"Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"31","author":"Loren","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2024.02.023_bib36","first-page":"147","article-title":"Fertility preservation in young women with early-stage breast cancer","volume":"58","author":"Vukovi\u0107","year":"2019","journal-title":"Acta Clin Croat"},{"issue":"164","key":"10.1016\/j.ajog.2024.02.023_bib37","article-title":"Cryopreservation of oocytes retrieved from ovarian tissue to optimize fertility preservation in prepubertal girls and women","author":"Brouillet","year":"2020","journal-title":"J\u00a0Vis Exp"},{"key":"10.1016\/j.ajog.2024.02.023_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.995172","article-title":"Fertility preservation in the pediatric population-experience from a German Cryobank for ovarian tissue","volume":"13","author":"Baston-B\u00fcst","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ajog.2024.02.023_bib39","doi-asserted-by":"crossref","DOI":"10.1177\/1179558119867357","article-title":"Ovarian tissue transplantation: experience from Germany and worldwide efficacy","volume":"13","author":"Lotz","year":"2019","journal-title":"Clin Med Insights Reprod Health"},{"key":"10.1016\/j.ajog.2024.02.023_bib40","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.3324\/haematol.2021.278828","article-title":"Successful pregnancies after transplantation of ovarian tissue retrieved and cryopreserved at time of childhood acute lymphoblastic leukemia \u2013 a case report","volume":"106","author":"Rodriguez-Wallberg","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.ajog.2024.02.023_bib41","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1182\/blood.2020007782","article-title":"Minimal residual disease quantification in ovarian tissue collected from patients in complete remission of acute leukemia","volume":"137","author":"Chevillon","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2024.02.023_bib42","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.fertnstert.2010.11.017","article-title":"Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis","volume":"95","author":"Bedaiwy","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2024.02.023_bib43","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ctrv.2013.12.001","article-title":"Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials","volume":"40","author":"Del Mastro","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ajog.2024.02.023_bib44","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/AOG.0000000000000905","article-title":"Protecting ovaries during chemotherapy through gonad suppression: a systematic review and meta-analysis","volume":"126","author":"Elgindy","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.02.023_bib45","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s43032-020-00206-6","article-title":"Recombinant anti-Mullerian hormone (rAMH) for stalling in\u00a0vitro granulosa cell replication","volume":"27","author":"Detti","year":"2020","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2024.02.023_bib46","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13256-020-02426-5","article-title":"Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with premature ovarian failure: two case reports and a review of the literature","volume":"14","author":"Igboeli","year":"2020","journal-title":"J\u00a0Med Case Rep"},{"key":"10.1016\/j.ajog.2024.02.023_bib47","first-page":"90","article-title":"Intraovarian injection of autologous platelet-rich plasma improves therapeutic approaches in the patients with poor ovarian response: a before-after study","volume":"16","author":"Navali","year":"2022","journal-title":"Int J Fertil Steril"},{"key":"10.1016\/j.ajog.2024.02.023_bib48","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.bbamcr.2012.07.013","article-title":"Mitochondrial ABC transporters function: the role of ABCB10 (ABC-me) as a novel player in cellular handling of reactive oxygen species","volume":"1823","author":"Liesa","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ajog.2024.02.023_bib49","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1042\/BST20150118","article-title":"Structures and functions of mitochondrial ABC transporters","volume":"43","author":"Schaedler","year":"2015","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.ajog.2024.02.023_bib50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s43556-021-00041-4","article-title":"Drug resistance: from bacteria to cancer","volume":"2","author":"Patel","year":"2021","journal-title":"Mol Biomed"},{"key":"10.1016\/j.ajog.2024.02.023_bib51","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1158\/1535-7163.MCT-16-0511","article-title":"The BTK inhibitor ibrutinib (PCI-32765) overcomes paclitaxel resistance in ABCB1- and ABCC10-overexpressing cells and tumors","volume":"16","author":"Zhang","year":"2017","journal-title":"Mol Cancer Ther"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824000942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824000942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T22:10:35Z","timestamp":1721686235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937824000942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0002937824000942"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2024.02.023","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fertility protection: a novel approach using pretreatment with mesenchymal stem cell exosomes to prevent chemotherapy\u2013induced ovarian damage in a mouse model","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2024.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}